Dihydromyricetin
- Generic Name
- Dihydromyricetin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H12O8
- CAS Number
- 27200-12-0
- Unique Ingredient Identifier
- KD8QND6427
- Background
Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus).
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- University of Guadalajara
- Target Recruit Count
- 24
- Registration Number
- NCT03606694
- Locations
- 🇲🇽
Instituto de TerapeĂştica Experimental y ClĂnica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath